About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Impact of Systematic Shaving on Margins | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT05782686

Impact of Systematic Shaving on Margins

The objective of this clinical trial is to demonstrate the reduction of positive margins in the definitive pathology of patients undergoing breast-conserving surgery with the systematic shaving techni...

Lead sponsor: Hospital Universitari de Bellvitge•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

amparo garcia-tejedor, MDPhD

CONTACT

932607695 agarciat@bellvitgehospital.cat

Sponsors

Lead Sponsor

Hospital Universitari de Bellvitge

Patients with breast cancer who undergo breast-conserving surgery are randomized in the operating room after lumpectomy into 2 groups of 117 patients each: shaving/no-shaving (standard surgery).

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•1. Breast-conserving surgery.
•2. Imaging diagnosis as the only breast tumor focus according to mammography, breast ultrasound and/or nuclear magnetic resonance;
•3. Pathological diagnosis of carcinoma in situ or infiltrating
•4. Oncoplastic without associated flaps;

Exclusion Criteria

•1. Male patients;
•2. Patients with a history of ipsilateral breast cancer.
•3. Oncoplastic that includes flaps
•4. Multifocality or multicentricity;
•5. Pregnant or lactating patient;
•6. Stage IV patients;
•7. Patients eligible for mastectomy;

Related studies

HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity

NCT07586215 · Breast Cancer Metastatic

RC48-ADC in HER2-low Advanced Breast Cancer

NCT05831878 · Advanced Breast Cancer

RECRUITINGPhase 1

Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

NCT07223983 · Alcohol Use Disorder, Weight Loss, and more

RECRUITINGPhase 2

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

NCT07368998 · Breast Cancer

RECRUITINGPhase 4

A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients

NCT07578064 · Breast Cancer, Bone Marrow Suppression

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 15, 2025Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment234

Start dateOct 2020

Last updatedSep 15, 2025

Condition

Margin, Tumor-Free Breast Cancer Surgery

Locations shown

Hospital de Bellvitge

L'Hospitalet de Llobregat, Barcelona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 15, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions